Sanos Clinic genopslog dette
We are super excited to share that our pioneering trial, PAKOA-001, has successfully screened and randomized its first participants at the Sanos Clinic in Herlev, Denmark! 🎉 PAKOA-001 is the first study to evaluate an innovative and easy-to-use approach for managing treatment expectations within a placebo-controlled trial, with the intent of reducing the placebo response and increase our ability to detect true effects of efficacious treatments. Through advanced sensory testing and detailed patient-reported measures, this project will provide critical insights into how study participants report their pain and how that affects the placebo response - insights that could transform how clinical trials are conducted worldwide. With a goal to enroll 150 participants across our three Sanos Clinics, this study reflects our commitment to making a meaningful impact on new treatment possibilities for patients in need. Led by our PhD Fellow Jakob Mejdahl Bentin, MD, supported by the NBCD and Sanos Science team, the project is partially funded by the Innovation Foundation Denmark. We’re also honored to collaborate with top experts, including Prof. Lars Arendt-Nielsen, a global expert in pain research at Aalborg University, and Prof. Lene Vase from Aarhus University, a global thought-leading scientist on placebo effects. At Sanos Group we are dedicated to advancing science and creating solutions that make a real difference. Stay tuned for more milestones to come! #ClinicalTrials #PlaceboResearch #NBCD #PatientImpact #partofSanosGroup